ArticleHeliyon2022

A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils.

Hiroshi Ohnishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.